Shaperon Inc. (KOSDAQ:378800)
972.00
-118.00 (-10.83%)
At close: Jun 8, 2026
Shaperon Market Cap
Shaperon has a market cap or net worth of 44.95 billion as of June 8, 2026. Its market cap has decreased by -48.22% in one year.
Market Cap
44.95B
Enterprise Value
23.93B
Revenue
281.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
972.00
Market Cap Chart
Since October 19, 2022, Shaperon's market cap has decreased from 191.86B to 44.95B, a decrease of -76.57%. That is a compound annual growth rate of -32.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 50.40B | -37.36% |
| Dec 30, 2025 | 80.46B | -23.73% |
| Dec 30, 2024 | 105.50B | 21.62% |
| Dec 28, 2023 | 86.75B | -45.62% |
| Dec 29, 2022 | 159.51B | -16.86% |
| Oct 19, 2022 | 191.86B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TegoScience | 65.33B |
| EyeGene | 63.98B |
| Progen | 62.27B |
| IMGT Co.,Ltd. | 62.02B |
| Aptamer Sciences | 54.39B |
| Psomagen | 52.71B |
| Quratis | 51.41B |
| ADBiotech | 49.20B |